Combating antimicrobial resistance: policy recommendations to save lives.
By B. Spellberg, Martina Blaser, Robert J Guidos, H. Boucher, J. Bradley, B. Eisenstein, D. Gerding, R. Lynfield, L. Reller, J. Rex and 4 more. Clinical Infectious Diseases, 2011
736 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, Infectious Diseases, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/a08a3b6fdc5fb3cfb2c7cd01d07933791d4045d8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Molecular Medicine
- F. Codjoe
- Carolina S. Silva
- M. O. Santos
- E. Donkor
- V. C. de Souza
- V. L. da Silva
- L. Tavares
- C. G. Diniz
Citations in the corpus
- Antibiotics and Bacterial Resistance in the 21st Century (2014, background): “β-lactams Biapenem (16), ceftaroline (11), doripenem (15), ertapenem Ceftobiprole, ceftolozane (12), razupenem (17)”
- Antimicrobial resistance: A global emerging threat to public health systems (2017, background): “Similarly, in the same period in the USA and China, AMR caused 100 000 and 80 000 deaths, respectively (Wei, 2009; Spellberg et al., 2011).”
- The global threat of antimicrobial resistance: science for intervention (2015, background): “policy makers at both national and international scales [13].”
- Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides (2013, background): “…that about two million Americans per year develop hospital infections, mostly caused by multidrug-resistant bacteria pathogens, which increases treatment costs in about U$ 21 million to U$ 34 billion, compared to antibiotic-susceptible pathogens (Roberts et al., 2009; Spellberg et al., 2011).”
- Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS) (2012, methodology): “A recent IDSA policy paper titled “Combating Antimicrobial Resistance: Policy Recommendations to Save Lives” has been issued.(34) It urges a strengthening of US efforts to improve prevention and control efforts, including the adoption of antimicrobial stewardship programs in all US healthcare facili”
- Carbapenem Resistance: A Review (2017, background): “[5] reported the annual costs of combating resistant bacterial infections to be between $21 billion and $34 billion in the USA alone.”